PAM SQUARED AT CORPUS CHRISTI — History
CCN 452086 | 3-year financial timeline | COVID resilience: 50/100
🛡️ Public data only — no PHI permitted on this instance.
$25M
Latest Revenue (FY2022)
+3.2%
Revenue CAGR (3yr)
21.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $24M | $24M | $25M | +5.3% | +3.2% |
| Operating Expenses | $18M | $19M | $20M | +5.8% | +4.8% |
| Operating Margin | 23.7% | 21.8% | 21.4% | -1.7% | -5.0% |
| Net Income | $6M | $5M | $5M | +3.5% | -1.9% |
| Licensed Beds | 41 | 41 | 41 | +0.0% | +0.0% |
| Total Patient Days | 12,971 | 13,114 | 12,905 | -1.6% | -0.3% |
| Medicare Day % | 56% | 48% | 54% | +12.4% | -2.4% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 50/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +6.6% ($24M → $25M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+3.2%
This Hospital
+7.6%
State Avg
Latest Margin
21.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $26M | 20.3% |
| FY2024 (proj) | $27M | 19.1% |
| FY2025 (proj) | $28M | 18.0% |